Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Cell Therapeutics Europe S.r.l

Femme Max 99 ans
Cell Therapeutics Europe S.r.l MAJ Il y a 4 ans

Phase II open label study of CT-2106 as a single agent in patients with advanced metastatic ovarian cancer who have failed one prior platinum and taxane based regimen To determine the overall response rate (complete plus partial response) of CT-2106 in patients with advanced ovarian cancer who have failed one prior platinum and taxane based regimen.

Pays Aucun
Organes Aucun
Spécialités Aucune

unknown

Plus d'informations